Back to Market Feed

KISQALI 400 MG DAILY DOSE

ribociclib
$346.9380per EA

Strength

200 mg/1

NDC

00078086742

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RIBOCICLIB SUCCINATE

Approval Type

New Drug (NDA)

FDA Application

NDA209092

On Market Since

3/13/2017

Pharmacological Classes

Cytochrome P450 3A Inhibitors
Kinase Inhibitor
Kinase Inhibitors

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.1%

Generic Alternatives

Save up to 16%

1 alternative • Same active ingredient

KISQALI 600 MG DAILY DOSE
Brand
00078087463•Novartis Pharmaceuticals Corporation
$289.7167
Save 16%

Related Drugs

Same classification

MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
KATERZIA 1 MG/ML SUSPENSION
Brand
52652500101•Azurity Pharmaceuticals Inc.
$4.1914
per ML
KALETRA 200-50 MG TABLET
Brand
00074401412•AbbVie Inc.
$8.3041
per EA
KALETRA 200-50 MG TABLET
Brand
00074679922•AbbVie Inc.
$8.3041
per EA
NORVIR 100 MG TABLET
Brand
00074234030•AbbVie Inc.
$8.3462
per EA
EXFORGE HCT 5-160-25 MG TAB
Brand
00078056015•Novartis Pharmaceuticals Corporation
$8.4511
per EA
EXFORGE HCT 10-160-12.5 MG TAB
Brand
00078056115•Novartis Pharmaceuticals Corporation
$8.4532
per EA
EXFORGE HCT 5-160-12.5 MG TAB
Brand
00078055915•Novartis Pharmaceuticals Corporation
$8.5559
per EA
NORVASC 5 MG TABLET
Brand
00069153068•Pfizer Inc.
$8.6824
per EA